CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$192M
1-Year Return
17.05%
This Quarter Return
-2.06%
1 Year Return
+17.05%
3 Year Return
+45.89%
5 Year Return
+105.96%
10 Year Return
+138.93%
AUM
$614M
AUM Growth
-$35.7M
(-5.5%)
Cap. Flow
-$20.7M
Cap. Flow
% of AUM
-3.37%
Top 10 Holdings %
Top 10 Hldgs %
8.77%
Holding
722
New
115
Increased
83
Reduced
345
Closed
120
Top Buys
| 1 |
Comcast
CMCSA
|
$3.16M |
| 2 |
Advanced Micro Devices
AMD
|
$2.26M |
| 3 |
Diamondback Energy
FANG
|
$2.23M |
| 4 |
PG&E
PCG
|
$2.17M |
| 5 |
Veeva Systems
VEEV
|
$2.05M |
Top Sells
| 1 |
Palo Alto Networks
PANW
|
$3.34M |
| 2 |
General Dynamics
GD
|
$2.93M |
| 3 |
Phillips 66
PSX
|
$2.76M |
| 4 |
Align Technology
ALGN
|
$2.65M |
| 5 |
L3Harris
LHX
|
$2.56M |
Sector Composition
| 1 | Financials | 18.85% |
| 2 | Technology | 17.63% |
| 3 | Healthcare | 12.62% |
| 4 | Industrials | 11.7% |
| 5 | Consumer Discretionary | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Air Products & Chemicals
APD
$64.5B
| $281K | 0.05% |
1,090
-107
| -9% | -$27.6K |
|
527
Chubb
CB
$111B
| $279K | 0.05% |
1,093
-33
| -3% | -$8.42K |
|
528
Iovance Biotherapeutics
IOVA
$905M
| $252K | 0.04% |
31,360
-297
| -0.9% | -$2.38K |
|
529
Automatic Data Processing
ADP
$120B
| $244K | 0.04% |
1,023
-20
| -2% | -$4.77K |
|
530
Cboe Global Markets
CBOE
$24.3B
| $236K | 0.04% |
1,387
| – | – |
|
531
Solventum
SOLV
$12.6B
| $236K | 0.04% |
+4,454
| New | +$236K |
|
532
Replimune Group
REPL
$494M
| $236K | 0.04% |
26,167
-326
| -1% | -$2.93K |
|
|
PSTX
533
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $231K | 0.04% |
79,223
-329
| -0.4% | -$961 |
|
534
TopBuild
BLD
$12.2B
| $227K | 0.04% |
590
| – | – |
|
535
Annexon
ANNX
$238M
| $226K | 0.04% |
46,057
-641
| -1% | -$3.14K |
|
536
Black Diamond Therapeutics
BDTX
$167M
| $224K | 0.04% |
48,110
-519
| -1% | -$2.42K |
|
|
537
Palo Alto Networks
PANW
$130B
| $223K | 0.04% |
1,314
-19,678
| -94% | -$3.34M |
|
538
Acuity Brands
AYI
$10.4B
| $215K | 0.04% |
890
-36
| -4% | -$8.69K |
|
539
Vir Biotechnology
VIR
$733M
| $200K | 0.03% |
22,524
-258
| -1% | -$2.3K |
|
540
Cullinan Oncology
CGEM
$413M
| $200K | 0.03% |
11,491
-7,088
| -38% | -$124K |
|
541
Tenaya Therapeutics
TNYA
$218M
| $198K | 0.03% |
63,838
-725
| -1% | -$2.25K |
|
542
Athira Pharma
ATHA
$15.1M
| $198K | 0.03% |
74,641
-748
| -1% | -$1.98K |
|
|
ITOS
543
DELISTED
iTeos Therapeutics
ITOS
| $195K | 0.03% |
13,119
-121
| -0.9% | -$1.8K |
|
544
Arcus Biosciences
RCUS
$1.3B
| $194K | 0.03% |
12,712
-105
| -0.8% | -$1.6K |
|
545
Entrada Therapeutics
TRDA
$201M
| $185K | 0.03% |
13,014
-129
| -1% | -$1.84K |
|
546
Vanda Pharmaceuticals
VNDA
$272M
| $184K | 0.03% |
32,561
-334
| -1% | -$1.89K |
|
547
Inovio Pharmaceuticals
INO
$148M
| $184K | 0.03% |
+22,712
| New | +$184K |
|
548
Voyager Therapeutics
VYGR
$235M
| $182K | 0.03% |
22,976
-241
| -1% | -$1.91K |
|
549
Enanta Pharmaceuticals
ENTA
$189M
| $178K | 0.03% |
13,760
-25
| -0.2% | -$324 |
|
550
First Horizon
FHN
$11.3B
| $178K | 0.03% |
11,270
+608
| +6% | +$9.59K |
|